Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standex International (SXI) Cash & Equivalents (2016 - 2025)

Standex International (SXI) has disclosed Cash & Equivalents for 16 consecutive years, with $97.0 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 19.93% to $97.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $97.0 million through Dec 2025, down 19.93% year-over-year, with the annual reading at $104.5 million for FY2025, 32.2% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $97.0 million at Standex International, down from $98.7 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $195.7 million in Q2 2023, with the low at $97.0 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $130.8 million, with a median of $128.8 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents surged 86.66% in 2023, then plummeted 40.06% in 2025.
  • Over 5 years, Cash & Equivalents stood at $147.2 million in 2021, then fell by 22.87% to $113.5 million in 2022, then grew by 25.49% to $142.4 million in 2023, then decreased by 14.94% to $121.1 million in 2024, then decreased by 19.93% to $97.0 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $97.0 million, $98.7 million, and $104.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.